Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease: A Large Case-Controlled Study (vol 71, pg 499, 2018)

被引：0
|
作者：
Fisk
机构：
来源：
HYPERTENSION | 2018年 / 72卷 / 03期
关键词：
D O I：
10.1161/HYP.0000000000000072
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E30 / E30
页数：1
相关论文
共 50 条
  • [1] Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease: A Large Case-Controlled Study
    Fisk, Marie
    McEniery, Carmel M.
    Gale, Nichola
    Maki-Petaja, Kaisa
    Forman, Julia R.
    Munnery, Margaret
    Woodcock-Smith, Jean
    Cheriyan, Joseph
    Mohan, Divya
    Fuld, Jonathan
    Tal-Singer, Ruth
    Polkey, Michael I.
    Cockcroft, John R.
    Wilkinson, Ian B.
    HYPERTENSION, 2018, 71 (03) : 499 - 506
  • [2] Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease (vol 72, pg 1126, 2018)
    Adamson, P. D.
    Anderson, J. A.
    Brook, R. D.
    Calverley, P. M. A.
    Celli, B. R.
    Cowans, N. J.
    Crim, C.
    Dixon, I. J.
    Martinez, F. J.
    Newby, D. E.
    Vestbo, J.
    Yates, J. C.
    Mills, N. L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (18) : 2282 - 2282
  • [3] Chronic Obstructive Pulmonary Disease as a Predictor of Cardiovascular Risk: A Case-Control Study
    Khanji, Mohammed Y.
    Stone, Ian S.
    Boubertakh, Redha
    Cooper, Jackie A.
    Barnes, Neil C.
    Petersen, Steffen E.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 17 (01) : 81 - 89
  • [4] Pneumococcal Vaccines in Chronic Obstructive Pulmonary Disease (vol 97, pg 463, 2018)
    Clark, Zachariah
    Maurer, Douglas
    AMERICAN FAMILY PHYSICIAN, 2019, 99 (01) : 5 - 5
  • [5] Chronic obstructive pulmonary disease as a cardiovascular risk factor: results of a case-control study (CONSISTE study)
    Falola, Michael
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2013, 8 : 105 - 105
  • [6] Cardiovascular risk factors in chronic obstructive pulmonary disease:: Results of the ARCE study
    de Lucas-Ramos, Pilar
    Luis Izquierdo-Alonso, Jose
    Rodriguez-Gonzalez Moro, Jose Miguel
    Maria Bellon-Cano, Jose
    Ancochea-Bermudez, Julio
    Calle-Rubio, Myrian
    Calvo-Corbella, Eduardo
    Molina-Paris, Jesus
    Perez-Rodriguez, Esteban
    Pons, Sonia
    ARCHIVOS DE BRONCONEUMOLOGIA, 2008, 44 (05): : 233 - 238
  • [7] THE APPLICABILITY OF CURRENT CARDIOVASCULAR RISK SCORES AND CARDIOVASCULAR SURROGATES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A CASE-CONTROL STUDY
    Stone, I. S.
    Khanji, M. J.
    James, W-Y
    Balawon, A.
    Boubertakh, R.
    John, L.
    Barnes, N. C.
    Petersen, S. E.
    THORAX, 2015, 70 : A85 - A86
  • [8] Chronic obstructive pulmonary disease exacerbation and risk of pulmonary embolism (vol 62, pg 103, 2007)
    Wedzicha
    Hurst
    THORAX, 2007, 62 (04) : 371 - 371
  • [9] Chronic obstructive pulmonary disease is not a risk factor for polyneuropathy: A prospective controlled study
    Visser, Nora A.
    Notermans, Nicolette C.
    van Berkhout, Ferdinand Teding
    van den Berg, Leonard H.
    Vrancken, Alexander F. J. E.
    CHRONIC RESPIRATORY DISEASE, 2017, 14 (04) : 327 - 333
  • [10] Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (vol 13, pg 651, 2018)
    Raparelli, Valeria
    Pastori, Daniele
    Pignataro, Serena Francesca
    Vestri, Anna Rita
    Pignatelli, Pasquale
    Cangemi, Roberto
    Proietti, Marco
    Davi, Giovanni
    Hiatt, William Robert
    Lip, Gregory Yoke Hong
    Corazza, Gino Roberto
    Perticone, Francesco
    Violi, Francesco
    Basili, Stefania
    INTERNAL AND EMERGENCY MEDICINE, 2018, 13 (08) : 1349 - 1349
12345